ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-12-31 was -$1.88M, a 6906.98% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-09-30 was $1.31M.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-06-30 was -$636.36K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2015-03-31 was $1.20M.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2015 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2014 was -$1.45K, a 100.41% decline from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2013 was $352.27K, a 150.83% increase from fiscal 2012.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2012 was $140.44K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed | Increase (Decrease) in Accounts Receivable 41 month | Increase (Decrease) in Accounts Receivable 44 month | Increase (Decrease) in Accounts Receivable 47 month | Increase (Decrease) in Accounts Receivable 50 month | Increase (Decrease) in Accounts Receivable 53 month | Increase (Decrease) in Accounts Receivable 56 month | Increase (Decrease) in Accounts Receivable 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | ||||||||||||||
| 2015-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$564.37K derived: sum of 2 quarters · filed 2016-03-30 | -$1.20M derived: sum of 3 quarters · filed 2017-03-21 | $0.00 10-K · filed 2016-03-30 | |||||||||||
| 2015-09-30 | $1.31M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2015-11-12 | $678.06K derived: sum of 2 quarters · filed 2017-03-21 | $1.88M 10-Q · filed 2015-11-12 | $1.91M derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2015-06-30 | -$636.36K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2017-03-21 | $564.37K 10-Q/A · filed 2017-03-21 | $2.28M 10-Q · filed 2015-08-06 | $591.98K derived: sum of 3 quarters · filed 2017-03-21 | $589.08K derived: sum of 4 quarters · filed 2017-03-21 | ||||||||||
| 2015-03-31 | $1.20M 10-Q · filed 2015-05-13 | $1.23M derived: sum of 2 quarters · filed 2016-03-30 | $1.23M derived: sum of 3 quarters · filed 2016-03-30 | $1.22M derived: sum of 4 quarters · filed 2016-03-30 | |||||||||||
| 2014-12-31 | $27.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $24.71K derived: sum of 2 quarters · filed 2016-03-30 | $18.35K derived: sum of 3 quarters · filed 2016-03-30 | -$1.45K 10-K · filed 2016-03-30 | $368.17K 10-K · filed 2015-03-30 | ||||||||||
| 2014-09-30 | -$2.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$9.26K derived: sum of 2 quarters · filed 2015-11-12 | -$29.05K 10-Q · filed 2015-11-12 | -$63.30K derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||
| 2014-06-30 | -$6.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$26.16K 10-Q · filed 2015-08-06 | -$60.41K derived: sum of 3 quarters · filed 2015-08-06 | -$52.65K derived: sum of 4 quarters · filed 2015-08-06 | |||||||||||
| 2014-03-31 | -$19.80K 10-Q · filed 2015-05-13 | -$54.04K derived: sum of 2 quarters · filed 2015-05-13 | -$46.29K derived: sum of 3 quarters · filed 2015-05-13 | $214.80K derived: sum of 4 quarters · filed 2015-05-13 | $474.14K 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | -$34.25K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$26.49K derived: sum of 2 quarters · filed 2015-03-30 | $234.59K derived: sum of 3 quarters · filed 2015-03-30 | $352.27K 10-K · filed 2015-03-30 | $493.93K 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | $7.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $268.84K derived: sum of 2 quarters · filed 2014-11-12 | $386.51K 10-Q · filed 2014-11-12 | $352.77K derived: sum of 4 quarters · filed 2014-11-12 | $528.18K 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | $261.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $378.76K 10-Q · filed 2014-08-12 | $345.02K derived: sum of 3 quarters · filed 2014-08-12 | $342.14K derived: sum of 4 quarters · filed 2014-08-12 | $520.42K 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $117.67K 10-Q · filed 2014-05-14 | -$117.67K 10-Q · filed 2013-05-15 | $83.93K derived: sum of 2 quarters · filed 2014-05-14 | $81.06K derived: sum of 3 quarters · filed 2014-05-14 | $302.23K derived: sum of 4 quarters · filed 2014-05-14 | -$259.34K 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | -$33.74K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$36.61K derived: sum of 2 quarters · filed 2014-03-27 | $184.55K derived: sum of 3 quarters · filed 2014-03-27 | $140.44K 10-K · filed 2014-03-27 | -$140.44K 10-K · filed 2013-03-28 | -$141.66K 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | -$2.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $218.29K derived: sum of 2 quarters · filed 2013-11-12 | $174.18K 10-Q · filed 2013-11-12 | -$174.18K 10-Q/A · filed 2013-01-22 | $172.96K derived: sum of 4 quarters · filed 2013-11-12 | -$175.41K 10-Q/A · filed 2013-01-22 | |||||||||
| 2012-06-30 | $221.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $177.06K 10-Q · filed 2013-08-14 | $175.83K derived: sum of 3 quarters · filed 2013-08-14 | ||||||||||||
| 2012-03-31 | -$44.11K 10-Q · filed 2013-05-15 | -$45.33K derived: sum of 2 quarters · filed 2013-05-15 | |||||||||||||
| 2011-12-31 | -$1.22K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | -$1.22K 10-K · filed 2013-03-28 | |||||||||||||
| 2011-09-30 | $0.00 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |